USPTO serial 90733679
MAB2
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 15, 2023
- Examiner
- KEELEY, ALISON REBECCA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MAB2?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Cambridge, GB
CAMBRIDGE, CB22 3AT, GB
CAMBRIDGE, CB22 3AT, GB
CAMBRIDGE, CB22 3AT, GB
WHITE CITY PLACE, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Shoko Naruo
Shoko Naruo THOMPSON COBURN LLPONE US BANK PLAZAST. LOUIS, MO 63101UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations containing monoclonal antibodies for scientific, industrial, and research use; bispecific and multispecific monoclonal antibodies, and fragments thereof, for scientific, industrial, and research use | ACTIVE | — |
| 005 | Pharmaceutical, biopharmaceutical and medical preparations, agents and substances, all containing or being monoclonal antibodies for medical purposes, and all for treatment of cancer, oncological diseases and disorders, infectious diseases and disorders, inflammation and diseases, disorders and conditions associated with inflammation, inflammatory diseases and disorders, and neurological diseases and disorders; bispecific and multispecific monoclonal antibodies for medical use; products in the nature of pharmaceutical preparations and medicines containing multispecific, in particular bispecific, monoclonal antibodies for use in medicine; diagnostic preparations, agents and substances, all containing or being monoclonal antibodies, for medical purposes | ACTIVE | — |
| 042 | Scientific and technological services, namely scientific research and design in the field of immunoglobulins and antibodies for medical purposes; scientific research, namely industrial analysis and research services, in the field of immunoglobulins and antibodies for medical purposes; pharmaceutical, scientific and biopharmaceutical research and development; medical research and development in the field of immunoglobulins and antibodies for medical purposes; drug discovery services; research relating to medicines; research and development of medicines; development of pharmaceutical and biopharmaceutical preparations and medicines; all of the foregoing involving monoclonal antibodies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by F-star Biotechnology Limited
- Other trademarks owned by F-STAR THERAPEUTICS LIMITED
- Other trademarks owned by F-STAR THERAPEUTICS LIMITED
- Other trademarks owned by F-STAR THERAPEUTICS LIMITED
- Other trademarks owned by INVOX PHARMA LIMITED
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MAB2
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 30, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 15, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 15, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 30, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 30, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 10, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 27, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 27, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 27, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 27, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 27, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 21, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 20, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 20, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 20, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 16, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 28, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 28, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 28, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 19, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 8, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 8, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 8, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 7, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 20, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 28, 2021 | NWAP | NEW APPLICATION ENTERED | — |